Gene · 85340
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reactivation of developmentally silenced globin genes through forced linear recruitment of remote enhancers. | Blood | 2025 | 40456162 | PubTator, text mining | PubMed |
| Assessment of periodontitis as a predictive sign of occurrence of type-II diabetes mellitus. | Saudi Dent J | 2025 | 40455344 | PubTator, text mining | PubMed |
| Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data. | Diabetologia | 2025 | 40450157 | PubTator, text mining | PubMed |
| Hematological and biochemical alterations in preeclampsia: Readings from cord blood analysis. | PLoS One | 2025 | 40446190 | PubTator, text mining | PubMed |
| Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy. | Diabetologia | 2025 | 40439773 | PubTator, text mining | PubMed |
| Implementation and Evaluation of a Best Practice Advisory to Reduce Inequities in Technology Use for People With Type 1 Diabetes: Protocol for a Mixed Methods, Nonrandomized Controlled Trial. | JMIR Res Protoc | 2025 | 40434817 | PubTator, text mining | PubMed |
| Structural Biology in the AlphaFold Era: How Far Is Artificial Intelligence from Deciphering the Protein Folding Code? | Biomolecules | 2025 | 40427567 | PubTator, text mining | PubMed |
| Effect of intensive glycemic control on the changes of diabetic retinopathy in type 2 diabetes: a prospective observational cohort study. | BMC Ophthalmol | 2025 | 40419975 | PubTator, text mining | PubMed |
| Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study. | Diabetologia | 2025 | 40404820 | PubTator, text mining | PubMed |
| Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with Metformin. | Diabetes Ther | 2025 | 40402403 | PubTator, text mining | PubMed |
| Skeletal muscle mitochondrial health in type 1 diabetes: the role of exercise capacity and lifestyle factors. | Diabetologia | 2025 | 40399597 | PubTator, text mining | PubMed |
| From cirrhosis to hepatogenous diabetes: risk factors and glycemic management. | Arch Med Sci | 2025 | 40395912 | PubTator, text mining | PubMed |
| Diabetes in Mayan Populations: Monitoring of Glycosylated Hemoglobin. | Ethn Dis | 2025 | 40386069 | PubTator, text mining | PubMed |
| mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes. | Nucleic Acids Res | 2025 | 40384581 | PubTator, text mining | PubMed |
| Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative review. | J Endocrinol Invest | 2025 | 40381155 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Transplantation in Severe Pediatric Sickle Cell Disease: Outcome and long-term complications, Saudi experience at King Faisal Specialist Hospital, Riyadh, Saudi Arabia. | Mediterr J Hematol Infect Dis | 2025 | 40375907 | PubTator, text mining | PubMed |
| Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial. | Sci Rep | 2025 | 40374694 | PubTator, text mining | PubMed |
| Clinicohematological and molecular analysis of hemoglobin D syndrome and unknown variants in the hemoglobinopathy spectrum of Sindh, Pakistan. | PLoS One | 2025 | 40373022 | PubTator, text mining | PubMed |
| ICVAE: Interpretable Conditional Variational Autoencoder for De Novo Molecular Design. | Int J Mol Sci | 2025 | 40362221 | PubTator, text mining | PubMed |
| Risk factors for recurrence of persistent atrial fibrillation after radiofrequency ablation and correlation with plasma miRNA expression. | Minerva Cardiol Angiol | 2025 | 40265566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85340/papers?page=7